PREVENAR 13 VACCINE contains Pneumococcal Polysaccharide Serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) conjugated with non-toxic diphtheria CRM197 protein. It is used in infants and toddlers (from 6 weeks to 5 years) to manage invasive diseases and otitis media caused by specific streptococcus pneumoniae serotypes. It is used in children and adolescents (from 6 years to 17 years) to manage invasive diseases caused by specific streptococcus pneumoniae serotypes. It is used in adults (above 18 years) to manage pneumonia and invasive diseases caused by specific streptococcus pneumoniae serotypes. Streptococcus pneumoniae, or pneumococcus, is a bacteria that may cause certain invasive diseases such as sepsis, meningitis, pleural empyema, and bacteremia. Sepsis is a life-threatening condition developed due to the extreme response of the body to the infection, which is characterised by symptoms such as confusion, dizziness, and diarrhoea. Meningitis is the infection of the membranes covering the brain, which is characterised by symptoms such as fever, headache, and stiff neck. Pleural empyema is a lung infection that causes pus formation in the membrane covering the lungs and is characterised by symptoms such as chest pain, dry cough, and fever. Bacteraemia is an infection of the blood that is characterised by symptoms such as fever, chills, and low blood pressure. Otitis media is an infection occurring in the middle ear, which is characterised by symptoms such as pain in the ears, headaches, and fever. Pneumonia is an infection occurring in the air sacs of one or both lungs that is characterised by symptoms such as fever, chills, and shortness of breath. PREVENAR 13 VACCINE is not recommended for use if you are allergic to pneumococcal polysaccharide serotypes or diphtheria toxoids. It should be used with caution in patients with chronic liver disease, chronic kidney disease, and nephrotic disease. PREVENAR 13 VACCINE should be used with...
No content available
